Nur Nicholson, Chief Technical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 3,714 shares at $66.81 ($248K) on 2024-01-16, disclosed to the SEC on 2024-01-17.
Open-market sale of $248k APLS by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.81 | 1,857 | $124K | 50.0% |
| 2 | $66.81 | 1,857 | $124K | 50.0% |
| Total | $66.81 avg | 3,714 | $248K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $58K | — | Filing → |
| APLS | SELL | 2025-01-30 | $24K | — | Filing → |
| APLS | SELL | 2025-01-23 | $240K | — | Filing → |